Entering text into the input field will update the search result below

Salix Pharmaceuticals to buy Santarus for $32/share

Nov. 07, 2013 4:14 PM ETSalix Pharmaceuticals, Ltd. (SLXP) StockSNTS, SLXPBy: Colin Lokey, SA News Editor2 Comments
  • Salix Pharmaceuticals (NASDAQ:SLXP) will acquire Santarus (NASDAQ:SNTS) for $32/share, a 38% premium to today's close, valuing the company at ~$2.6B. (PR)

Recommended For You

Related Stocks

SymbolLast Price% Chg
SLXP--
Salix Pharmaceuticals, Ltd.
To ensure this doesn’t happen in the future, please enable Javascript and cookies in your browser.
Is this happening to you frequently? Please report it on our feedback forum.
If you have an ad-blocker enabled you may be blocked from proceeding. Please disable your ad-blocker and refresh.